← back to search

Paula M. Cannon

University of Southern California · US
🔎 Find collaborators in Virology · Genetics →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Virology · Genetics
Research interest
Research interests include HIV Research and Treatment, Virus-based gene therapy research, CRISPR and Genetic Engineering, and Cytomegalovirus and herpesvirus research.
h-index
43
citations
6,880
works
126
NIH funding
primary concept
Biology
email

Recent publications

Engineering B cells to express fully customizable antibodies with enhanced Fc functions.
2026cited by 0position: contributordoi
Unveiling alternate pathways for SARS-CoV-2 infection via extracellular vesicle-mediated transfer of ACE2 and TMPRSS2.
2026cited by 0position: contributordoi
Breakthroughs in targeted in vivo gene editing: Overcoming barriers to effective delivery.
2025cited by 0position: contributordoi
Engineering B cells to express fully customizable antibodies with enhanced Fc functions
2025cited by 0position: contributordoi
Engineering B cells to Express Fully Customizable Antibodies with Enhanced Fc Functions
2025cited by 0position: contributordoi
Reprogramming human B cells with custom heavy-chain antibodies.
2024cited by 15position: contributordoi
Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides.
2023cited by 5position: contributordoi
Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides
2023cited by 0position: contributordoi
Reprogramming human B cells with custom heavy-chain antibodies
2023cited by 0position: contributordoi
Reprogramming human B cells with custom heavy chain antibodies
2023cited by 0position: contributordoi
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
Nature Medicine 2021cited by 362position: middledoi
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.
2021cited by 290position: contributordoi
Rational Selection of CRISPR-Cas9 Guide RNAs for Homology-Directed Genome Editing.
2021cited by 39position: contributordoi
Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytes.
2021cited by 36position: contributordoi
Cytoplasmic Tail Truncation of SARS-CoV-2 Spike Protein Enhances Titer of Pseudotyped Vectors but Masks the Effect of the D614G Mutation.
2021cited by 23position: contributordoi
Genome edited B cells: a new frontier in immune cell therapies.
2021cited by 20position: contributordoi
Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytes
2021cited by 1position: contributordoi
Knockdown of astrocytic monocarboxylate transporter 4 (MCT4) in the motor cortex leads to loss of dendritic spines and a deficit in motor learning
2021cited by 0position: contributordoi
Reprogramming the antigen specificity of B cells using genome-editing technologies
eLife 2019cited by 101position: middledoi
Homologous recombination-based genome editing by clade F AAVs is inefficient in the absence of a targeted DNA break
2019cited by 0position: contributordoi
Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR–Cas9 genome-editing efficiency
Nature Biotechnology 2017cited by 294position: middledoi
Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression
Nature Communications 2017cited by 44position: middledoi
International AIDS Society global scientific strategy: towards an HIV cure 2016
Nature Medicine 2016cited by 421position: middledoi
AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges
Nature 2015cited by 301position: middledoi
Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors
Nature Biotechnology 2015cited by 263position: lastdoi
Genome Editing Technologies: Defining a Path to Clinic
Molecular Therapy 2015cited by 99position: middledoi

Grants

B cells as boostable factories for HIV inhibition
NIH1P01HL183483-01$516,9862025–2030Contact PIRePORTER
Nuclear receptor regulation of epigenetic mechanisms regulating HIV CNS latency
NIH1R01MH134316-01$745,1792023–2028PIRePORTER
Nuclear receptor regulation of epigenetic mechanisms regulating HIV CNS latency
NIH5R01MH134316-02$724,3252023–2028PIRePORTER
Nuclear receptor regulation of epigenetic mechanisms regulating HIV CNS latency
NIH5R01MH134316-03$718,5532023–2028PIRePORTER
Gene edited B cells to co-express CNS-targeted antibodies
NIH5R21MH130178-02$247,5002022–2024Contact PIRePORTER
Gene edited B cells to co-express CNS-targeted antibodies
NIH1R21MH130178-01$206,2502022–2024Contact PIRePORTER
Reversing Immune Dysfunction for HIV-1 Eradication
NIH5UM1AI164561-05$5,028,8902021–2026PIRePORTER
Reversing Immune Dysfunction for HIV-1 Eradication
NIH1UM1AI164561-01$5,001,8072021–2021PIRePORTER
Reversing Immune Dysfunction for HIV-1 Eradication
NIH5UM1AI164561-04$5,001,0892021–2026PIRePORTER
In vivo engineering of B cells for the secretion of HIV broadly neutralizing antibodies
NIH5R01AI167003-02$738,5812021–2026PIRePORTER
In vivo engineering of B cells for the secretion of HIV broadly neutralizing antibodies
NIH5R01AI167003-03$733,6312021–2026PIRePORTER
In vivo engineering of B cells for the secretion of HIV broadly neutralizing antibodies
NIH5R01AI167003-04$700,1742021–2026PIRePORTER
In vivo engineering of B cells for the secretion of HIV broadly neutralizing antibodies
NIH1R01AI167003-01$645,7462021–2026PIRePORTER
In vivo engineering of B cells for the secretion of HIV broadly neutralizing antibodies
NIH5R01AI167003-05$571,8082021–2026PIRePORTER
In vivo engineering of B cells for the secretion of HIV broadly neutralizing antibodies
NIH3R01AI167003-05S1$145,8962021–2026PIRePORTER
Novel hematopoietic stem cell engineering and transplantation approaches for HIV cure
NIH1U19HL156247-01$3,085,1052020–2025Contact PIRePORTER
Novel hematopoietic stem cell engineering and transplantation approaches for HIV cure
NIH5U19HL156247-03$2,978,4752020–2025Contact PIRePORTER
Novel hematopoietic stem cell engineering and transplantation approaches for HIV cure
NIH5U19HL156247-02$2,658,1782020–2025Contact PIRePORTER
Novel hematopoietic stem cell engineering and transplantation approaches for HIV cure
NIH5U19HL156247-05$2,334,0362020–2026Contact PIRePORTER
Administrative Core
NIH1U19AI149676-01$514,1852020–Contact PIRePORTER
Administrative Core
NIH5U19HL156247-04$345,7082020–2025Contact PIRePORTER
Targeted inactivation of HIV in CNS reservoirs
NIH5R01MH113457-02$740,4732017–2022Contact PIRePORTER
Targeted inactivation of HIV in CNS reservoirs
NIH5R01MH113457-03$737,2862017–2022Contact PIRePORTER
Targeted inactivation of HIV in CNS reservoirs
NIH5R01MH113457-04$735,0902017–2022Contact PIRePORTER
Targeted inactivation of HIV in CNS reservoirs
NIH5R01MH113457-05$732,0932017–2023Contact PIRePORTER

Frequent collaborators

· 17 papers (2019–2026)Geoffrey Rogers · University of California, San Diego6 papers (2023–2026)Atishay Mathur · University of Southern California3 papers (2024–2026)Ya-Wen Chen · Regenerative Medicine Institute2 papers (2021–2026)Ben Murrell · Karolinska Institutet1 papers (2019–2019)Pedro A. Mateos‐Gómez · New York University1 papers (2017–2017)Michal Zimmermann · Telesta Therapeutics (Canada)1 papers (2017–2017)Marcus D. Wilson · University of Edinburgh1 papers (2017–2017)Min Yu · University of Maryland, Baltimore1 papers (2026–2026)Laura E. McCoy · Institute of Infection and Immunity1 papers (2019–2019) · 1 papers (2017–2017) · 1 papers (2019–2019)Michael W. Jakowec · Alfred Mann Foundation1 papers (2021–2021)Sachdev S. Sidhu · University of Waterloo1 papers (2017–2017)Amélie Fradet‐Turcotte · Université Laval1 papers (2017–2017)Devin Sok · Scripps Research Institute1 papers (2019–2019)George N. Llewellyn · University of Southern California1 papers (2015–2015)Donald B. Kohn · University of California, Berkeley1 papers (2015–2015)Gang Bao · Harbin Institute of Technology1 papers (2015–2015)Khoa Le · Aarhus University1 papers (2019–2019)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Virology · Genetics →